Prime Medicine, Inc.PRMENASDAQ
Loading
Year-over-year net income growth rate
Latest
8.90%
↑ 103% vs avg
Percentile
P81
Within normal range
Streak
3 qtr
Consecutive growthAccelerating
Average
-284.20%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 8.90% |
| Q3 2025 | 3.82% |
| Q2 2025 | -1.35% |
| Q1 2025 | -22.74% |
| Q4 2024 | 19.50% |
| Q3 2024 | 5.08% |
| Q2 2024 | -20.90% |
| Q1 2024 | 30.29% |
| Q4 2023 | -29.45% |
| Q3 2023 | -19.64% |
| Q2 2023 | -7.58% |
| Q1 2023 | -0.29% |
| Q4 2022 | -10.00% |
| Q3 2022 | -21.68% |
| Q2 2022 | -23.10% |
| Q1 2022 | 62.11% |
| Q4 2021 | -283.32% |
| Q3 2021 | -2764.29% |
| Q2 2021 | 100.71% |
| Q1 2021 | -3278.56% |
| Q4 2020 | 0.00% |
| Q4 2019 | 0.00% |